Cargando…
Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation
Abelmoschus manihot (L.) Medik. (Malvaceae) is a herb used in traditional Chinese medicine to treat some kidney diseases. To date, the detailed mechanisms by which A. manihot improves some kinds of renal disease are not fully understood. In this study, we established Adriamycin-induced NRK-52E cells...
Autores principales: | Li, Wei, He, Weiming, Xia, Ping, Sun, Wei, Shi, Ming, Zhou, Yao, Zhu, Weiwei, Zhang, Lu, Liu, Buhui, Zhu, Jingjing, Zhu, Yiye, Zhou, Enchao, Sun, Minjie, Gao, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548014/ https://www.ncbi.nlm.nih.gov/pubmed/31191310 http://dx.doi.org/10.3389/fphar.2019.00567 |
Ejemplares similares
-
Total extract of Abelmoschus manihot L. alleviates uric acid-induced renal tubular epithelial injury via inhibition of caspase-8/caspase-3/NLRP3/GSDME signaling
por: Ding, Zhihui, et al.
Publicado: (2022) -
Chalcone Derivatives From Abelmoschus manihot Seeds Restrain NLRP3 Inflammasome Assembly by Inhibiting ASC Oligomerization
por: Su, Jinsong, et al.
Publicado: (2022) -
Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
por: Yu, Hongmei, et al.
Publicado: (2023) -
Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
por: Zhao, Yue, et al.
Publicado: (2020) -
The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease
por: Wei, Cuiting, et al.
Publicado: (2023)